Malaria Vaccine Market by Product Type, Distribution Channel, End User 2022-2030

1
Global Malaria Vaccine Market Research and
Forecast Report 2022-2030

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "Malaria Vaccine Market Global Industry
  Trends, Share, Size, Growth, Opportunity and
  Forecast 2022-2030," the global malaria vaccine
  market is expected to exhibit a CAGR of around
  34 during 2022-2030.
• Malaria vaccines are biological components that
  promote the formation of antibodies to reduce the
  risk of developing malaria, a disease caused by
  the plasmodium parasite, which is spread to
  humans through the bites of infected mosquitoes.
  It is generally characterized by headaches,
  chills, fever, fatigue, nausea, and other
  symptoms.
• Some commonly used malaria vaccines include
  pre-erythrocytic, erythrocytic, and multi-antigen
  vaccines. They can be administered through
  intramuscular, subcutaneous, and intradermal
  injections. In recent years, malaria vaccines
  have gained immense traction across the globe to
  prevent the risk of contracting malaria.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/malaria-vaccine-market/
  requestsample

4
Report Description

• Global Malaria Vaccine Market Trends
• The rising prevalence of malaria, especially
  across tropical countries, represents the primary
  factor driving the market growth. Moreover, the
  development of anti-infective or pre-erythrocytic
  vaccines that kill the plasmodium parasite and
  prevent the progression of chronic blood-stage
  disorders is positively influencing market
  growth. Additionally, numerous favorable
  initiatives by various government and
  non-government organizations to spread awareness
  about the importance of immunization and disease
  prevention among the masses are other major
  growth-inducing factors. Along with this, the
  increasing number of routine immunization
  programs in various countries, particularly in
  the endemic and rural regions, is propelling the
  market growth.
• Besides this, the rising focus of pharmaceutical
  companies on the development of new and improved
  malaria vaccines by accelerating the clinical
  trials of various pipeline drugs has catalyzed
  market growth. Furthermore, numerous
  technological advancements, including the
  introduction of novel adjuvants and innovative
  vaccination delivery platforms, are contributing
  to the market growth. Other factors, including
  ongoing research and development (RD)
  activities, the launch of innovative product
  variants, extensive investments in improving
  healthcare infrastructure, and increasing funding
  for vaccine development programs, are also
  anticipated to create a favorable market outlook.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/malaria-vaccine-market

5
Report Segmentation

• Breakup by Type
• Pre-Erythrocytic Vaccine
• Erythrocytic Vaccine
• Multi-Antigen Vaccine
• Others
•  
• Breakup by Agent
• Plasmodium Falciparum
• Plasmodium Vivax
• Anopheles Species
• Breakup by Route of Administration
• Intramuscular
• Subcutaneous
• Intradermal
• Others

6
Report Segmentation

• Breakup by Distribution Channel
• NGO/Non-Profit Organization
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others
• Breakup by Region
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

7
Key Questions Answered in the Report
8
Key Questions Answered in the Report
9
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4  
   Introduction    4.1    Overview    4.2    Key
  Industry Trends5    Global Malaria Vaccine
  Market    5.1    Market Overview    5.2  
   Market Performance    5.3    Impact of
  COVID-19  5.4    Market Forecast
• 6     Market Breakup by Type
• 6.1 Pre-Erythrocytic Vaccine
• 6.2 Erythrocytic Vaccine
• 6.3 Multi-Antigen Vaccine
• 6.4 Others
• 7 Market Breakup by Agent
• 7.1 Plasmodium Falciparum
• 7.2 Plasmodium Vivax
• 7.3 Anopheles Species       

10
Table of Contents

• 8 Market Breakup by Route of Administration
• 8.1 Intramuscular
• 8.2 Subcutaneous
• 8.3 Intradermal
• 8.4 Others
• 9 Market Breakup by Distribution Channel
• 9.1 NGO/Non-Profit Organization
• 9.2 Hospital Pharmacy
• 9.3 Retail Pharmacy
• 9.4 Online Pharmacy
• 9.5 Others
• 10 Market Breakup by Region
• 10.1 North America
• 10.2 Asia-Pacific
• 10.3 Europe
• 10.4 Latin America
• 10.5 Middle East and Africa
• 11 SWOT Analysis
• 11.1 Overview

11
Disclaimer

• 2023 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

12
Contact Us
Visit us at
https//www.imarcgroup.com
TELEPHONE [phone] E-MAIL
sales_at_imarcgroup.com